- Home
- MAGN vs IMRX Comparison
MAGN vs IMRX Comparison
Compare MAGN & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAGN
- IMRX
- Stock Information
- Founded
- MAGN 1864
- IMRX 2008
- Country
- MAGN United States
- IMRX United States
- Employees
- MAGN N/A
- IMRX N/A
- Industry
- MAGN Paper
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- MAGN Basic Materials
- IMRX Health Care
- Exchange
- MAGN Nasdaq
- IMRX Nasdaq
- Market Cap
- MAGN 67.4M
- IMRX 73.2M
- IPO Year
- MAGN N/A
- IMRX 2021
- Fundamental
- Price
- MAGN $17.21
- IMRX $1.94
- Analyst Decision
- MAGN
- IMRX Buy
- Analyst Count
- MAGN 0
- IMRX 7
- Target Price
- MAGN N/A
- IMRX $12.60
- AVG Volume (30 Days)
- MAGN 1.2M
- IMRX 369.8K
- Earning Date
- MAGN 01-01-0001
- IMRX 11-13-2024
- Dividend Yield
- MAGN N/A
- IMRX N/A
- EPS Growth
- MAGN N/A
- IMRX N/A
- EPS
- MAGN N/A
- IMRX N/A
- Revenue
- MAGN $2,175,000,000.00
- IMRX N/A
- Revenue This Year
- MAGN N/A
- IMRX N/A
- Revenue Next Year
- MAGN N/A
- IMRX N/A
- P/E Ratio
- MAGN $68.89
- IMRX N/A
- Revenue Growth
- MAGN N/A
- IMRX N/A
- 52 Week Low
- MAGN $15.86
- IMRX $1.00
- 52 Week High
- MAGN $35.23
- IMRX $8.89
- Technical
- Relative Strength Index (RSI)
- MAGN N/A
- IMRX 51.04
- Support Level
- MAGN N/A
- IMRX $1.68
- Resistance Level
- MAGN N/A
- IMRX $1.97
- Average True Range (ATR)
- MAGN 0.00
- IMRX 0.13
- MACD
- MAGN 0.00
- IMRX -0.01
- Stochastic Oscillator
- MAGN 0.00
- IMRX 71.72
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.